Mobile app for alcohol cessation in liver disease patients
Official title: Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease (IMPACT-ALD): Aim 1
Run by University of Wisconsin, Madison · NCT06305624 · Data updated 2026-11-12
This study is testing whether a smartphone app can help people with alcohol-related liver disease stop drinking more effectively than just regular care alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 298 (estimated) |
| Sponsor | University of Wisconsin, Madison Academic / other |
| Locations | 3 sites (Lansing, Michigan and 2 other locations) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | October 31, 2027 |
| Study ends | October 31, 2027 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT06305624 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with any stage of alcohol-associated liver disease who have consumed alcohol in the last 6 months and are receiving care at the participating medical centers.
✕Probably not a fit
Patients who are actively listed for liver transplant, in hospice care, or have severe cognitive impairment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of the CHESS Health Connections smartphone application in helping patients with alcohol-associated liver disease (ALD) achieve alcohol cessation. Conducted at two major medical centers in Michigan and Wisconsin, the trial will enroll 298 participants who will be monitored for up to 6 months. The study compares the outcomes of patients using the app alongside usual care to those receiving only usual care, aiming to improve abstinence rates and liver function. Additionally, qualitative interviews will assess the implementation of the app within clinical settings.
Why it matters
Potential benefit: If successful, this approach could significantly enhance alcohol cessation rates and improve liver health in patients with alcohol-associated liver disease.
How similar studies have gone: Previous studies have shown promise in using mobile health applications for alcohol cessation, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (Aim 1): * Diagnosis of ALD (any stage) * Alcoholic liver disease (ALD) encompasses a spectrum of hepatic injuries caused by long-term alcohol abuse. For this study, participants will have a diagnosis of ALD or evidence of the combination of liver disease and alcohol misuse in electronic health record. * Alcohol use within the last 6 months * Receiving care at UW or Henry Ford Health + MSU * Either the general hepatology clinic or the multidisciplinary ALD clinic * Able to read and write proficiently in English * Willing and able to use a smartphone app Exclusion Criteria: * Actively listed for liver transplant or history of liver transplant before being enrolled in the study. Participants added to a liver transplant list after being enrolled in the study will be allowed to continue their participation * In hospice care * Has severe cognitive impairment (as described in electronic health record including dementia, delirium, and/or unable to maintain cognitive alertness during screening--as determined by study staff.)
Where it's running
-
Henry Ford + Michigan State University Health Center
Lansing, Michigan, United States Recruiting -
UW General Hepatology Clinic
Madison, Wisconsin, United States Recruiting -
UW Multidisciplinary ALD Clinic
Madison, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Andrew Quanbeck, PhD — University of Wisconsin, Madison
- Study coordinator: Jared P McDonald, MBA
- Email: jared.mcdonald@fammed.wisc.edu
- Phone: 608-263-4022
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Peer support for liver transplant recipients with a history of alcohol use disorder
This study tests whether having a peer support specialist helps liver transplant recipients with prior alcohol use disorder stay abstinent and stay engaged in care.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Thiamine to reduce brain injury in adults with alcohol use disorder
This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.
-
Endurance exercise to see if it lowers alcohol use in adults with AUD and ALD
A 12-week home-based cycling program added to standard care is tested to see if it reduces alcohol use and cravings in adults with alcohol use disorder and alcohol-related liver disease.
-
Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit
This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.
-
Path180: a computer-based skills program to help teens reduce alcohol use
This 8-week trial tests Path180, a computer-based skills training, added to usual care for teens 13–19 with alcohol use disorder to see if it improves daily-life coping skills and outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.